论文部分内容阅读
Technologies for diabetes management, such ascontinuous subcutaneous insulin infusion （CSII） andcontinuous glucose monitoring （CGM） systems, haveimproved remarkably over the last decades. Thesedevelopments are impacting the capacity to achieverecommended